ADA-friendly PDF: Correlation of Extreme Drug Resistance Assay Results and Progression-Free Survival Following Intraperitoneal Chemotherapy for Advanced Ovarian Cancer

Correlation of Extreme Drug Resistance Assay Results and Progression-Free Survival Following Intraperitoneal Chemotherapy for Advanced Ovarian Cancer

Ovarian Cancer accounts for 27% of gynecologic cancers and 54% of disease-related deaths.